ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

NCI Advisors Approve Research Network On Screening

August 6, 2010

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999